Objective:To systematically review the efficacy and safety of botulinum toxin A injection for the spastic equinus foot in children with cerebral palsy by analyzing the domestic and foreign relevant literature. Methods:All relevant controlled clinical re-searches(randomized controlled trials,RCTs) about the efficacy and safety of botulinum toxin A injection for the spastic equinus foot in children with cerebral palsy from Cochrane Collaboration,Cochrane Library,Medline,PubMed,Chinese periodical full-text database,Wanfang Standards Database and other Chinese and English database were searched,as well as the relevant literatures and confer-ence proceedings. Quality of enrolled literatures was assessed;Meta analysis calculations are made by ReyMan 5.3. Results:A total of seven studies with a total of 576 cases were enrolled including 360 cases of botulinum toxin A and 216 cases of placebo. There was no significant differences in the incidence of adverse events(RR=1.40,95%CI=0.99 to 1.97,P=0.06) between botulinum toxin A and placebo in the treatment of the spastic equinus foot in cerebral palsy. In the gait analysis(RR=2.29,95%CI=1.56 to 3.37,P=0.000),There were significant differences in the degree of dynamic muscle spasm(MD=8.76,95%CI=5.86 to 11.66,P=0.000),the degree of arrest muscle spasm(MD=4.88,95%CI=0.96 to 8.80,P=0.01),quality of life change difference(RR=1.49,95%CI=1.08 to 2.06,P=0.02) between two groups. Conclusion:Botulinum toxin A in-jection for the spastic equinus foot in children with cerebral palsy is safe and effective. Therefore,it is worth promoting and applying in clinic.